Search for: "State v. Kirin"
Results 1 - 20
of 43
Sorted by Relevance
|
Sort by Date
10 May 2018, 11:12 pm
Remington [1990] FSR 181; and Kirin-Amgen v. [read post]
15 May 2014, 11:40 am
On the principle of the matter, he stated at 111:In my judgment this reasoning [from Rohm & Haas] is persuasive, and it is supported by the subsequent judgment of the Court of Appeal in Virgin v Premium. [read post]
10 Dec 2014, 12:31 am
What Birss J has now done is to say "The EPO approach to the interpretation is a novelty rule, not a construction rule, and Kirin-Amgen shows that to be so". [read post]
1 Nov 2019, 6:02 am
In Neo v Anan Kasei([2019]EWCA Civ 1646) the Court of Appeal again considered the thorny issue of insufficiency, both the Kirin-Amgenand the Biogen kind. [read post]
29 Apr 2015, 7:24 pm
The class action lawsuit (Parent v. [read post]
7 Sep 2010, 6:10 pm
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to Kirin Amgen,… [read post]
28 Mar 2018, 8:14 am
VEGF-Trap is therefore one of those improvements which Lord Hoffmann had in mind in Kirin-Amgen [2004] UKHL 46, [2005] RPC 9 at [117]. [read post]
26 Jun 2015, 12:30 am
Floyd LJ has roundly rejected Arnold J's reasoning, stating:58.The difficulty I feel with endorsing this reasoning is as follows. [read post]
13 May 2015, 7:58 am
Oliva et al. v. [read post]
8 Nov 2017, 5:29 am
Jurisprudence has evolved in the UK, Germany, Netherlands and other member states. [read post]
19 Jan 2018, 3:58 am
The inventor's views and corresponding documents may be used to try and define claim scope, obviousness, novelty, and the state of the art. [read post]
12 Jul 2017, 1:34 pm
" That led the court to a consideration of prior English case law as well of that of other EPC member states. [read post]
12 Jul 2017, 7:59 am
" That led the court to a consideration of prior English case law as well of that of other EPC member states. [read post]
22 Jan 2017, 11:49 am
Seeking an ArrowArrow declarations can be granted: Fujifilm v AbbVieGuestKat Eibhlin Vardy discusses Fujifilm Kyowa Kirin Biologics Co., Ltd v AbbVie Biotechnology Ltd & Anor [2017] EWCA Civ 1, which involves two appeals, both raising the question of whether a Court can grant a so called ‘Arrow declaration’, i.e. a declaration that “a product was old or obvious in patent law terms at a particular date”.Guest Post - China's Patent… [read post]
17 Jul 2017, 3:39 pm
This GuestKat has noted with interest comments which suggest that this case opens the way to a doctrine of "file wrapper estoppel" in the UK, but wonders whether the case really goes much further than existing UK case law which has admitted reference to the file in cases of "admissions against interest" - see for example Rohm & Haas v Collag [2002] F.S.R. 28 and Furr v Truline [1985] F.S.R. 553. [read post]
13 Jul 2017, 8:47 am
The judgment comes as a surprise, as the previously established UK case law had over time firmly done away with the idea of ‘pith and marrow’ infringement, culminating in the seminal House of Lords judgment in Kirin-Amgen v Hoechst Marion Roussel [2004] UKHL 46. [read post]
13 Jul 2017, 8:47 am
The judgment comes as a surprise, as the previously established UK case law had over time firmly done away with the idea of ‘pith and marrow’ infringement, culminating in the seminal House of Lords judgment in Kirin-Amgen v Hoechst Marion Roussel [2004] UKHL 46. [read post]
25 Jun 2019, 9:28 am
However, the Court also states (“superfluously”) that even if this would have been the case the Court’s conclusion would remain the same. [read post]
28 Jul 2011, 3:00 am
Claim 3, stated to have independent validity, was attacked on grounds of obviousness – it being alleged to lack inventive step over three pieces of prior art (Qin, Lassen and ‘746) and the common general knowledge. [read post]
30 Jul 2015, 9:50 am
That is what today's decision addresses.Appeal to the Supreme CourtThe Court of Appeal has refused leave for Smith & Nephew to appeal to the Supreme Court, because it considered that there is no significant point of general public importance at stake, since it has done no more than apply the established principles of claim construction from Kirin Amgen (Kirin Amgen Inc v Hoechst Marion Roussel Ltd [2004] UKHL 46, [2005] RPC 9) to the case before it. [read post]
